Novartis to Buy Glaxo Cancer Drugs, Sell Animal Health

Novartis AG will focus more on cancer, GlaxoSmithKline Plc on vaccines and Eli Lilly & Co. on animal health as the drugmakers announced a series of deals for a total of as much as $28.5 billion today.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.